| Literature DB >> 8545851 |
G Ambrus1, E Ilköy, A Jekkel, G Horváth, Z Böcskei.
Abstract
The genetically modified Mycobacterium sp. BCS 396 strain has been used to transform sterols with stigmastane side chain in order to obtain 26-oxidized metabolites. beta-Sitosterol (I) was transformed to 4-stigmasten-3-one (II), 26-hydroxy-4-stigmasten-3-one (III), and 3-oxo-4-stigmasten-26-oic acid (IV), while stigmasterol (V) was converted to 4,22-stigmastadien-3-one (VI), 6 beta-hydroxy-4,22-stigmastadien-3-one (VII), 26-hydroxy-4,22-stigmastadien-3-one (VIII), 3-oxo-4,22-stigmastadien-26-oic acid methyl ester (IX), and 3-oxo-1,4,22-stigmastatrien-26-oic acid methyl ester (X) with that strain. In both beta-sitosterol and stigmasterol, 26-oxidation generates the R-configuration on C-25.Entities:
Mesh:
Substances:
Year: 1995 PMID: 8545851 DOI: 10.1016/0039-128x(95)00077-4
Source DB: PubMed Journal: Steroids ISSN: 0039-128X Impact factor: 2.668